MedTrace Logo

Tranexamic Acid in Debridement Surgery of Burns on the Volume of Bleeding in Transfusion Requirements

NCT05855590 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-05-11

No results posted yet for this study

Summary

Tranexamic acid in debridement surgery of burns on the volume of bleeding in transfusion requirements

Conditions

  • Burns

Interventions

DRUG

Tranexamic acid

10mg/kg intravenous single dose

OTHER

0.9% isotonic saline solution

100 ml intravenous single dose

Sponsors & Collaborators

  • Instituto Mexicano del Seguro Social

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-01-01
Completion
2023-12-30

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05855590 on ClinicalTrials.gov